Registration - Amendment

ASTELLAS GENE THERAPIES, INC. A DELAWARE CORPORATION for ASTELLAS GENE THERAPIES, INC. A DELAWARE CORPORATION

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Transparency Policy Issues, Medicare Part D, Coverage Gap, Rebate Reform, Out-of-Pocket Costs, International Reference Pricing, Oncology Screening Awareness, Value-based Payment Arrangements for Gene Therapy; Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Policy Issues, Issues related to Patient Drug User Fee Reauthorization.

LobbyistCovered position, as disclosed
STEPHEN RUBRIGHT New Military Legislative Assistant and Foreign Policy Advisor for Sen. Kay Bailey Hutchison (TX); Military Legislative Assistant to Rep. Jeff Miller (FL-01).

Health Issues HCR

Transparency Policy Issues, Medicare Part D, Coverage Gap, Rebate Reform, Out-of-Pocket Costs, International Reference Pricing, Oncology Screening Awareness, Value-based Payment Arrangements for Gene Therapy; Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Policy Issues, Issues related to Patient Drug User Fee Reauthorization.

LobbyistCovered position, as disclosed
STEPHEN RUBRIGHT New Military Legislative Assistant and Foreign Policy Advisor for Sen. Kay Bailey Hutchison (TX); Military Legislative Assistant to Rep. Jeff Miller (FL-01).

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTELLAS PHARMA INC. (THROUGH 100% OWNERSHIP OF ASTELLAS US HOLDING, INC.) Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.